CareDx announced that it has reached a significant licensing agreement with Eurobio Scientific.

According to the terms of the agreement, Eurobio Scientific has granted CareDx the permanent exclusive right to distribute its in vitro diagnostic reagents in North America. This strategic cooperation will significantly expand CareDx’s product portfolio in the field of transplant diagnostics and strengthen its leadership position in the North American market. By obtaining the exclusive distribution rights to Eurobio Scientific’s innovative diagnostic technology, CareDx is able to provide more comprehensive solutions to clinicians and patients. The granting of permanent exclusive rights establishes a long-term and stable foundation for CareDx’s business growth, while also demonstrating Eurobio Scientific’s full confidence in CareDx’s market development capabilities. This partnership is expected to generate significant synergies and further enhance CareDx’s competitiveness in the field of transplant diagnostics.